Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 5/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | JAK2 | O60674 | 2/20 | 0.41 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.41 |
| ▸ | PRKACA | P17612 | 2/20 | 0.41 |
| ▸ | CDK2 | P24941 | 2/20 | 0.41 |
| ▸ | KDR | P35968 | 2/20 | 0.41 |
| ▸ | GSK3B | P49841 | 2/20 | 0.41 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.41 |
| ▸ | CDC7 | O00311 | 1/20 | 0.41 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.41 |
| ▸ | PAK4 | O96013 | 1/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.41 |
| ▸ | HIPK2 | Q9H2X6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Manogepix SCHEMBL30518388 | 1.00 | NPC1 (0.41) | NPC1ALDH1A1CYP2C19CYP2D6RAB9A | |
| Manogepix SCHEMBL30375321 | 1.00 | NPC1 (0.41) | NPC1ALDH1A1CYP2C19CYP2D6RAB9A | |
| Manogepix SCHEMBL1323608 | 0.99 | NPC1 (0.41) | NPC1ALDH1A1CYP2C19CYP2D6RAB9A | |
| Manogepix SCHEMBL1323256 | 0.99 | NPC1 (0.41) | NPC1ALDH1A1CYP2C19CYP2D6RAB9A | |
| Manogepix SCHEMBL1322997 | 0.99 | NPC1 (0.41) | NPC1ALDH1A1CYP2C19CYP2D6RAB9A | |
| Manogepix SCHEMBL1322796 | 0.99 | NPC1 (0.41) | NPC1ALDH1A1CYP2C19CYP2D6RAB9A | |
| Manogepix SCHEMBL1323272 | 0.94 | NPC1 (0.37) | NPC1ALDH1A1CYP2C19CYP2D6RAB9A | |
| Manogepix SCHEMBL1322795 | 0.94 | NPC1 (0.37) | NPC1ALDH1A1CYP2C19CYP2D6RAB9A | |
| Manogepix SCHEMBL1323004 | 0.92 | CDC7 (0.36) | NPC1ALDH1A1CYP2C19CYP2D6RAB9A | |
| Manogepix SCHEMBL3468507 | 0.92 | CDC7 (0.38) | NPC1ALDH1A1CYP2C19CYP2D6RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210163461-A1 | HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2021-06-03 | — | — | US | claimed |
| EP-3720438-A1 | HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS | Amplyx Pharmaceuticals, Inc. (US) | 2020-10-14 | — | — | EP | claimed |
| CN-111698989-A | Heterocyclic substituted pyridine derivative antifungal agent | 安普利克斯制药公司 | 2020-09-22 | — | — | CN | claimed |
| WO-2019113542-A1 | HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS | AMPLYX PHARMACEUTICALS, INC. (US) | 2019-06-13 | — | — | WO | claimed |
| EP-2628738-B1 | Heterocyclic substituted pyridine derivatives and antifungal agent containing same | EISAI R&D MAN CO LTD (JP) | 2014-09-03 | — | — | EP | claimed |
| US-20130288956-A1 | COMBINED PHARMACEUTICAL COMPOSITION AS ANTIFUNGAL AGENT | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2013-10-31 | — | — | US | claimed |
| EP-2636409-A1 | COMBINED PHARMACEUTICAL COMPOSITION AS ANTIFUNGAL AGENT | Eisai R&D Management Co., Ltd. (JP) | 2013-09-11 | — | — | EP | claimed |
| EP-2628738-A1 | Heterocyclic substituted pyridine derivatives and antifungal agent containing same | Eisai R&D Management Co., Ltd. (JP) | 2013-08-21 | — | — | EP | claimed |
| EP-1944303-B1 | PYRIDINE DERIVATIVE SUBSTITUTED BY HETEROCYCLE AND FUNGICIDE CONTAINING THE SAME | EISAI R&D MAN CO LTD (JP) | 2013-08-21 | — | — | EP | claimed |
| US-8058444-B2 | acid salt of 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-yl amine; inhibiting fungal GPI (glycosylphosphatidyl-inositol) biosynthesis and expression of cell wall proteins; antifungal agents; active against azole-resistant fungi; preventive or therapeutic agent for fungal infections | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-11-15 | — | — | US | claimed |
| US-7691882-B2 | 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine; inhibiting fungal GPI biosynthesis thereby inhibiting expression of cell wall proteins and blocking cell wall assembly while preventing the fungus from attaching to cells | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2010-04-06 | — | — | US | claimed |
| EP-2143723-A1 | SALT OF HETEROCYCLE-SUBSTITUTED PYRIDINE DERIVATIVE OR CRYSTAL THEREOF | Eisai R&D Management Co., Ltd. (JP) | 2010-01-13 | — | — | EP | claimed |
| US-20080275244-A1 | HETEROCYCLE-SUBSTITUTED PYRIDINE DERIVATIVE'S SALT OR CRYSTAL THEREOF | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2008-11-06 | — | — | US | claimed |
| CN-121914097-A | Five-membered heteroaryl compound and application thereof | 成都安礼特医药科技有限公司 | 2026-04-24 | — | — | CN | disclosed |
| US-20250101012-A1 | HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2025-03-27 | — | — | US | disclosed |
| US-12139479-B2 | Heterocycle substituted pyridine derivative antifungal agents | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2024-11-12 | — | — | US | disclosed |
| EP-1944303-A1 | PYRIDINE DERIVATIVE SUBSTITUTED BY HETEROCYCLE AND FUNGICIDE CONTAINING THE SAME | Eisai R&D Management Co., Ltd. (JP) | 2008-07-16 | — | — | EP | disclosed |
| US-20070105904-A1 | 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine; inhibiting fungal GPI biosynthesis thereby inhibiting expression of cell wall proteins and blocking cell wall assembly while preventing the fungus from attaching to cells | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070105904-A1 | 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine; inhibiting fungal GPI biosynthesis thereby inhibiting expression of cell wall proteins and blocking cell wall assembly while preventing the fungus from attaching to cells | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070105904-A1 | 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine; inhibiting fungal GPI biosynthesis thereby inhibiting expression of cell wall proteins and blocking cell wall assembly while preventing the fungus from attaching to cells | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250101012-A1 | HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS | ERG28, DPM1, CYP51A1 | NPC1 194/4885ALDH1A1 2033/4885CYP2C19 38/4885 |
| US-20210163461-A1 | HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS | ERG28, DPM1, CYP51A1 | NPC1 194/4885ALDH1A1 2033/4885CYP2C19 38/4885 |
| US-20130288956-A1 | COMBINED PHARMACEUTICAL COMPOSITION AS ANTIFUNGAL AGENT | DPM1, MTMR1, CHAMP1 | NPC1 515/4885ALDH1A1 4390/4885CYP2C19 416/4885 |
| US-12139479-B2 | Heterocycle substituted pyridine derivative antifungal agents | ERG28, DPM1, CYP51A1 | NPC1 194/4885ALDH1A1 2033/4885CYP2C19 38/4885 |
| US-20070105904-A1 | 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine; inhibiting fungal GPI biosynthesis thereby inhibiting expression of cell wall proteins and blocking cell wall assembly while preventing the fungus from attaching to cells | GPI, ERG28, MAN2A1 | NPC1 1201/4885ALDH1A1 3327/4885CYP2C19 707/4885 |
| US-20080275244-A1 | HETEROCYCLE-SUBSTITUTED PYRIDINE DERIVATIVE'S SALT OR CRYSTAL THEREOF | PDXK, REN, JAK2 | NPC1 4237/4885ALDH1A1 2213/4885CYP2C19 698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.